281 related articles for article (PubMed ID: 21304949)
1. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes.
Lappano R; Recchia AG; De Francesco EM; Angelone T; Cerra MC; Picard D; Maggiolini M
PLoS One; 2011 Jan; 6(1):e16631. PubMed ID: 21304949
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update.
Abdalkareem Jasim S; Kzar HH; Haider Hamad M; Ahmad I; Al-Gazally ME; Ziyadullaev S; Sivaraman R; Abed Jawad M; Thaeer Hammid A; Oudaha KH; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():109074. PubMed ID: 35978522
[TBL] [Abstract][Full Text] [Related]
3. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.
Umetani M; Ghosh P; Ishikawa T; Umetani J; Ahmed M; Mineo C; Shaul PW
Cell Metab; 2014 Jul; 20(1):172-82. PubMed ID: 24954418
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
5. Re-adopting classical nuclear receptors by cholesterol metabolites.
Umetani M
J Steroid Biochem Mol Biol; 2016 Mar; 157():20-6. PubMed ID: 26563834
[TBL] [Abstract][Full Text] [Related]
6. Going off the grid: ERα breast cancer beyond estradiol.
Perone Y; Magnani L
J Mol Endocrinol; 2016 Jul; 57(1):F1-5. PubMed ID: 27151575
[TBL] [Abstract][Full Text] [Related]
7. Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol.
Vini R; Juberiya AM; Sreeja S
IUBMB Life; 2016 Feb; 68(2):116-21. PubMed ID: 26756990
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-generated 27-hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha.
Tian W; Pang W; Ge Y; He X; Wang D; Li X; Hou H; Zhou D; Feng S; Chen Z; Yang Y
J Cell Biochem; 2018 Mar; 119(3):2929-2938. PubMed ID: 29130512
[TBL] [Abstract][Full Text] [Related]
9. Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
Padró M; Louie RJ; Lananna BV; Krieg AJ; Timmerman LA; Chan DA
BMC Cancer; 2017 Mar; 17(1):203. PubMed ID: 28320353
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
11. The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes.
Recchia AG; De Francesco EM; Vivacqua A; Sisci D; Panno ML; Andò S; Maggiolini M
J Biol Chem; 2011 Mar; 286(12):10773-82. PubMed ID: 21266576
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol and breast cancer pathophysiology.
Nelson ER; Chang CY; McDonnell DP
Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418
[TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer.
Vini R; Lekshmi A; Ravindran S; Thulaseedharan JV; Sujathan K; Rajavelu A; Sreeja S
J Cell Mol Med; 2023 Sep; 27(18):2744-2755. PubMed ID: 37614064
[TBL] [Abstract][Full Text] [Related]
14. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.
Raza S; Ohm JE; Dhasarathy A; Schommer J; Roche C; Hammer KD; Ghribi O
Mol Cell Biochem; 2015 Dec; 410(1-2):187-95. PubMed ID: 26350565
[TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage.
Hsieh DJ; Kuo WW; Lai YP; Shibu MA; Shen CY; Pai P; Yeh YL; Lin JY; Viswanadha VP; Huang CY
Cell Physiol Biochem; 2015; 36(1):274-84. PubMed ID: 25967966
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
17. Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines.
Woo SY; Lee H; Park SM; Choi HS; Kim J; Kwon M; Sohn J; Nam JH; Kim HS; Song P; Baryawno N; Kim YH; Kim K; Lee D
Cell Death Dis; 2022 Oct; 13(10):916. PubMed ID: 36316327
[TBL] [Abstract][Full Text] [Related]
18. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
[TBL] [Abstract][Full Text] [Related]
19. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.
Wu Q; Ishikawa T; Sirianni R; Tang H; McDonald JG; Yuhanna IS; Thompson B; Girard L; Mineo C; Brekken RA; Umetani M; Euhus DM; Xie Y; Shaul PW
Cell Rep; 2013 Nov; 5(3):637-45. PubMed ID: 24210818
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
